{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:24Z","timestamp":1789055664340,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.dld.2020.12.010","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T14:12:34Z","timestamp":1610460754000},"page":"1451-1457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)"],"prefix":"10.1016","volume":"53","author":[{"given":"Luca","family":"Miele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianxhela","family":"Dajko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Zocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Magistris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso F.","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Biolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Maccora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venanzio","family":"Valenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Riso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Di Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2020.12.010_bib0001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000444018","article-title":"An age-standardized prevalence estimate and a sex and age distribution of myotonic dystrophy types 1 and 2 in the Rome Province, Italy","volume":"46","author":"Vanacore","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.dld.2020.12.010_bib0002","series-title":"Myotonic dystrophy","author":"Vydra","year":"2020"},{"key":"10.1016\/j.dld.2020.12.010_bib0003","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fneur.2019.01229","article-title":"Insulin signaling as a key moderator in myotonic dystrophy type 1","volume":"10","author":"Nieuwenhuis","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.dld.2020.12.010_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184987","article-title":"Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle","volume":"12","author":"Renna","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2020.12.010_bib0005","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4","article-title":"Clinical and genetic heterogeneity in myotonic dystrophies","volume":"23","author":"Meola","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.dld.2020.12.010_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1665-2681(19)31497-8","article-title":"Abnormal liver function tests in a patient with myotonic dystrophy type 1","volume":"11","author":"Kalafateli","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0007","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-199806000-00016","article-title":"Abnormal liver test results in myotonic dystrophy","volume":"26","author":"Achiron","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2020.12.010_bib0008","article-title":"Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy","author":"Shieh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.dld.2020.12.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2020.12.010_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0012","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"Stine","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2020.12.010_bib0013","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0014","first-page":"557","article-title":"Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: a meta-analysis with bias analysis","volume":"39","author":"Morrison","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"Suppl 1","key":"10.1016\/j.dld.2020.12.010_bib0015","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dld.2020.12.010_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","article-title":"Liver cancer: connections with obesity, fatty liver, and cirrhosis","volume":"67","author":"Marengo","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.dld.2020.12.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/570356","article-title":"Diabetes and insulin therapy, but not metformin, are related to hepatocellular cancer risk","volume":"2015","author":"Miele","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2020.12.010_bib0018","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0019","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2020.12.010_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00394","article-title":"High prevalence and gender-related differences of gastrointestinal manifestations in a cohort of DM1 patients: a perspective, cross-sectional study","author":"Perna","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.dld.2020.12.010_bib0021","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dld.2020.12.010_bib0022","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.56.3.336","article-title":"Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy","volume":"56","author":"Mathieu","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.dld.2020.12.010_bib0023","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0024","article-title":"It's all about balance: propensity score matching in the context of complex survey data","volume":"20","author":"D","year":"2019","journal-title":"Biostat Oxf Engl"},{"key":"10.1016\/j.dld.2020.12.010_bib0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/eci.12459","article-title":"Gonadal failure is associated with visceral adiposity in myotonic dystrophies","volume":"45","author":"Passeri","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2020.12.010_bib0026","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.dld.2020.12.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214254","article-title":"Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies","volume":"14","author":"Renna","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2020.12.010_bib0028","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archneur.63.8.1149","article-title":"Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1","volume":"63","author":"Heatwole","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.dld.2020.12.010_bib0029","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1445-5994.2008.01871.x","article-title":"Anicteric cholestasis: an unusual presentation of myotonic dystrophy","volume":"39","author":"Syn","year":"2009","journal-title":"Intern Med J"},{"key":"10.1016\/j.dld.2020.12.010_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03347199","article-title":"Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome","volume":"28","author":"Marchesini","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.dld.2020.12.010_bib0031","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2005.06.018","article-title":"Hepatic steatosis and insulin resistance: does etiology make a difference?","volume":"44","author":"Lonardo","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2020.12.010_bib0032","article-title":"Mechanisms for increased risk of diabetes in chronic liver diseases","author":"Svegliati-Baroni","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2020.12.010_bib0033","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep4.1411","article-title":"Impact of implementing a \u201cFIB-4 first\u201d strategy on a pathway for patients with NAFLD referred from primary care","volume":"3","author":"Davyduke","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.dld.2020.12.010_bib0034","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.13739","article-title":"Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease","volume":"38","author":"Bertot","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2020.12.010_bib0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnagi.2015.00125","article-title":"Muscle wasting in myotonic dystrophies: a model of premature aging","volume":"7","author":"Mateos-Aierdi","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.dld.2020.12.010_bib0036","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2020.12.010_bib0037","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jcsm.12598","article-title":"Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey","volume":"11","author":"Kang","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.dld.2020.12.010_bib0038","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.dld.2020.12.010_bib0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-018-0776-0","article-title":"Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis","volume":"18","author":"Yu","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2020.12.010_bib0040","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820310926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820310926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:39Z","timestamp":1761625119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865820310926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1590865820310926"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2020.12.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2020.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}